Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neuroleptic”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Ended earlyNCT01913327
What this trial is testing

Antipsychotic Effects on Brain Function in Schizophrenia

Who this might be right for
SchizophreniaSchizoaffective DisorderSchizophreniform Disorder
University of California, San Francisco 4
Not applicableStudy completedNCT00223522
What this trial is testing

Do Self-Report and Physician Impressions of Adherence to Oral Antipsychotic Medication Agree With Objective Data?

Who this might be right for
SchizophreniaSchizoaffective
The University of Texas Health Science Center at San Antonio 50
Not applicableStudy completedNCT01152697
What this trial is testing

Customized Adherence Enhancement Plus Long-acting Injectable Antipsychotic

Who this might be right for
Patient Noncompliance
University Hospitals Cleveland Medical Center 30
Not applicableUnknownNCT03693794
What this trial is testing

A Study in Italy About Evidence Based Psychosocial/Rehabilitative Interventions in Patients With Early Schizophrenia Treated Continuously With Antipsychotics

Who this might be right for
Schizophrenia
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia 270
Post-approval studies (Phase 4)Study completedNCT00594269
What this trial is testing

Dementia Antipsychotics And Antidepressants Discontinuation Study

Who this might be right for
Dementia
Sykehuset Innlandet HF 149
Post-approval studies (Phase 4)Study completedNCT00191828
What this trial is testing

A Study on Induced Weight Gain During Atypical Antipsychotic Treatment and Its Management With Psychoeducational Programme

Who this might be right for
Weight Gain
Eli Lilly and Company 60
Not applicableStudy completedNCT01739127
What this trial is testing

Comparison of Aripiprazole Versus Higher Metabolic Risk Antipsychotic Drugs on Adiposity Using MRI

Who this might be right for
Psychotic DisordersBipolar DisorderMetabolic Syndrome X
University of British Columbia 83
Post-approval studies (Phase 4)Study completedNCT00292370
What this trial is testing

Quetiapine Augmentation for Treatment-resistant PTSD

Who this might be right for
Combat DisordersStress Disorders, Post-Traumatic
VA Office of Research and Development 124
Not applicableNot Yet RecruitingNCT05850585
What this trial is testing

The Efficacy of Fecal Microbiota Transplantation(FMT) in the Treatment of Schizophrenia

Who this might be right for
Schizophrenia
First Affiliated Hospital Xi'an Jiaotong University 100
Not applicableStudy completedNCT01347619
What this trial is testing

IADAPT: Off Label Use of Antipsychotics in the Nursing Home

Who this might be right for
Off-label Use of Atypical Antipsychotic Drugs
University of Massachusetts, Worcester 42
Large-scale testing (Phase 3)Ended earlyNCT00704509
What this trial is testing

Efficacy of Bifeprunox in Patients With Schizophrenia

Who this might be right for
Schizophrenia
H. Lundbeck A/S 346
Post-approval studies (Phase 4)UnknownNCT02562287
What this trial is testing

Clozapine Versus Other Atypical Antipsychotics for Bipolar Disorder

Who this might be right for
Bipolar Disorder
Hospital de Clinicas de Porto Alegre 54
Testing effectiveness (Phase 2)UnknownNCT02650102
What this trial is testing

The Role of miR-30 Family Dysregulation in Response to Antipsychotic Treatment

Who this might be right for
Schizophrenia
Shanxi Medical University 200
Large-scale testing (Phase 3)Study completedNCT00250367
What this trial is testing

The Effectiveness and Safety of Risperidone Versus Placebo as add-on Therapy to Mood Stabilizers, in the Treatment of Manic Episodes Associated With Bipolar Disorder.

Who this might be right for
Bipolar DisorderManic Disorder
Janssen Pharmaceutica N.V., Belgium 151
Early research (Phase 1)Not Yet RecruitingNCT07715253
What this trial is testing

Longitudinal PET Imaging of Antipsychotic Binding to the Dopamine-3 Receptor in Schizophrenia

Who this might be right for
Schizoaffective DisorderSchizophreniform DisorderSchizophrenia
New York State Psychiatric Institute 100
Post-approval studies (Phase 4)Study completedNCT00014001
What this trial is testing

CATIE- Schizophrenia Trial

Who this might be right for
Schizophrenia
National Institute of Mental Health (NIMH) 1,600
Testing effectiveness (Phase 2)Ended earlyNCT02820519
What this trial is testing

Tolerability and Analgesic Efficacy of Loxapine in Patients With Refractory, Chemotherapy-induced Neuropathic Pain

Who this might be right for
Neuropathic Pain
University of Witten/Herdecke 4
Post-approval studies (Phase 4)Study completedNCT01609153
What this trial is testing

Comparison of Antipsychotic Combination Treatment of Olanzapine and Amisulpride to Monotherapy

Who this might be right for
SchizophreniaSchizoaffective Disorder
Heinrich-Heine University, Duesseldorf 328
Large-scale testing (Phase 3)Study completedNCT00257075
What this trial is testing

The Effectiveness and Safety of Risperidone Versus Placebo in the Treatment of Manic Episodes Associated With Bipolar I Disorder

Who this might be right for
Bipolar DisordersManic Episode
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 267
Large-scale testing (Phase 3)Study completedNCT00177164
What this trial is testing

Risperdal Consta for Bipolar Disorder

Who this might be right for
Bipolar I Disorder
University of Pittsburgh 50
Next Page